Compound Summary
Compound Name: | (S)-(-)-Propranolol hydrochloride |
Compound CID: | 165193 |
Synonyms: | (S)-(-)-Propranolol hydrochloride 4199-10-4 (S)-Propranolol hydrochloride Levopropranolol hydrochloride UNII-YP6GDU0L78 More... |
Iupac Name: | (2S)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride |
InChI: | InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H/t14-;/m0./s1 |
InChIKey: | ZMRUPTIKESYGQW-UQKRIMTDSA-N |
Canonical Smiles: | CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl |
Isomeric Smiles: | CC(C)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O.Cl |
Molecular Weight: | 295.8 |
Molecular Formula: | C16H22ClNO2 |
Molecular Weight: | 295.8 |
Molecular Formula: | C16H22ClNO2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 20 |
Complexity: | 257 |
(S)-(-)-Propranolol hydrochloride | (S)-(-)-Propranolol hydrochloride |
---|---|
(S)-(-)-Propranolol hydrochloride |
4199-10-4 |
(S)-Propranolol hydrochloride |
Levopropranolol hydrochloride |
UNII-YP6GDU0L78 |
YP6GDU0L78 |
MFCD00064547 |
(S)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride |
(2S)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride |
(2S)-1-(naphthalen-1-yloxy)-3-(propan-2-yl)aminopropan-2-ol hydrochloride |
(S)-Propranolol HCl |
C16H21NO2.HCl |
SR-01000076087 |
(S)-1-(isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride |
(2s)-1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol hydrochloride |
EINECS 224-096-0 |
SCHEMBL41689 |
MLS000859887 |
SPECTRUM1500514 |
CHEMBL545328 |
S(-)-Propranolol hydrochloride |
DTXSID50873367 |
Propranolol hydrochloride, (-)- |
(S)-()-Propranolol hydrochloride |
HMS1920L20 |
Pharmakon1600-01500514 |
(S)-(-)-PROPRANOLOL HCL |
(S)-(2-Hydroxy-3-(naphthyloxy)propyl)isopropylammonium chloride |
Tox21_501023 |
(2S)-(-)-Propanolol Hydrochloride |
4395AH |
NSC757295 |
s5981 |
AKOS015960770 |
CCG-212772 |
LP01023 |
NSC-757295 |
VC30037 |
VC30279 |
1-ALLYL-35-DIMETHYLPYRAZOLE96 |
2-Propanol,1-(1-methylethyl)amino-3-(1-naphthalenyloxy)-, hydrochloride (1:1), (2S)- |
NCGC00261708-01 |
AC-12294 |
AS-61344 |
SMR000326749 |
B6466 |
EU-0101023 |
A13428 |
P 8688 |
SR-01000597856 |
SR-01000076087-1 |
SR-01000076087-5 |
SR-01000076087-6 |
SR-01000597856-1 |
Q27294637 |
(S)-(-)-Propranolol hydrochloride, >=98% (TLC), powder |
UNII-F8A3652H1V component ZMRUPTIKESYGQW-UQKRIMTDSA-N |
(2S)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride (1:1) |
(S)-(-)-1-(1-methylethyl)amino-3-(1-naphthalenyloxy)-2-propanol hydrochloride |
2-Propanol,1-(1-methylethyl)amino-3-(1-naphthalenyloxy)-, hydrochloride (1:1), (2R)- |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 14.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 14.000000000000000 | 1 | 1 |